BCM
MDXG icon

Bayesian Capital Management’s MiMedx Group MDXG Stock Holding History

Bayesian Capital Management’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,010
Closed -$76.3K – 907
2024
Q2 		$76.3K Buy
+11,010
New +$77.4K 0.01% 660
2024
Q1 		– Sell
-10,319
Closed -$90.5K – 979
2023
Q4 		$90.5K Buy
+10,319
New +$75.6K 0.01% 661
2022
Q3 		– Sell
-12,533
Closed -$43K – 900
2022
Q2 		$43K Buy
+12,533
New +$49.1K 0.01% 719
2017
Q4 		– Sell
-10,500
Closed -$125K – 653
2017
Q3 		$125K Buy
+10,500
New +$156K 0.03% 449
2017
Q1 		– Sell
-21,200
Closed -$188K – 586
2016
Q4 		$188K Buy
+21,200
New +$190K 0.05% 533

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bayesian Capital Management's MDXG Position: Q3 2024 in Review

Bayesian Capital Management sold out of MiMedx Group (MDXG) in Q3 2024, closing a stake of 11,010 shares — an estimated $76.3K sold.

Bayesian Capital Management first reported a position in MDXG in Q4 2016 and held it in 5 quarters. The position peaked at $188K in Q4 2016. 194 funds tracked by Wall St. Rank hold MDXG as of Q3 2024.

  • Bayesian Capital Management reported no remaining MiMedx Group position as of Q3 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 11,010 MiMedx Group shares in Q3 2024, an estimated $76.3K.
  • Bayesian Capital Management first reported a position in MiMedx Group in Q4 2016 and held it in 5 quarters.
  • Bayesian Capital Management's MiMedx Group position peaked at $188K in Q4 2016.
  • 194 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2024.

Based on Bayesian Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.